A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India
NCT ID: NCT02047526
Last Updated: 2014-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medtronic South Asian Systolic Heart Failure Registry
NCT01434615
Demographic and Clinical Characteristics, Treatment Patterns and Clinical Outcomes of Heart Failure Patients in China
NCT03931200
A Clinical Follow-up Study of Heart Failure Patients.
NCT03797742
Heart Failure Evaluation Study
NCT05583513
Manipal Heart Failure Registry (MHFR)
NCT03157219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Female or male aged 18 years and over
3. All patients with Dyspnea and/or signs of systemic congestion
Exclusion Criteria
2. Absence of cardiac disease/structural heart disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ammar Raza, MBBS, DIP DIAB, MBA
Role: STUDY_DIRECTOR
AstraZeneca Pharma India Ltd.
R R Kasliwal, DM
Role: PRINCIPAL_INVESTIGATOR
Medanta, The Medicity, Gurgaon
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HF Registry-India
Identifier Type: -
Identifier Source: secondary_id
NIS-CIN-XXX-2012/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.